Evidence map›Paper›PMID 30941133›Full record

ArticleFrontiers in immunology2019

A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against

Saugata Majumder, Shreya Das, Vikas Kumar Somani, Shivakiran S Makam, Joseph J Kingston, Rakesh Bhatnagar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Human anthrax vaccines: Current status and future prospects.Human vaccines & immunotherapeutics · 2025
    Review
  2. Article
  3. Article
  4. Polysaccharide PCP-I isolated fromHuman vaccines & immunotherapeutics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Saugata MajumderDefence Food Research Laboratory, Microbiology Division, Defence Research Development Organisation, Mysore, India.
Shreya DasDefence Food Research Laboratory, Microbiology Division, Defence Research Development Organisation, Mysore, India.
Vikas Kumar SomaniSchool of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Shivakiran S MakamDefence Food Research Laboratory, Microbiology Division, Defence Research Development Organisation, Mysore, India.
Joseph J KingstonDefence Food Research Laboratory, Microbiology Division, Defence Research Development Organisation, Mysore, India.
Rakesh BhatnagarSchool of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Defence Food Research Laboratory · INJawaharlal Nehru University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthrax vaccines primarily relying only on protective antigen (PA), the cell binding component in anthrax toxins provide incomplete protection when challenged with spores of virulent encapsulated

Indexed as

Anthrax VaccinesAnimalsAnthraxAntibodies, BacterialAntigens, BacterialBacillus anthracisBacterial ToxinsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesExotoxinsFemaleImmunizationImmunoglobulin GMacrophagesMiceMice, Inbred BALB Canthrax toxinAnthrax VaccinesAntibodies, BacterialAntigens, BacterialBacterial ToxinsExotoxinsImmunoglobulin GanthraxBxpBPAprotectionspore challenge

Identifiers

PMID30941133
PMCPMC6433990
OpenAlexW2924670569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.